News

With a lack of real breakthroughs since the 1960s, older methods such as electrical-based therapies are experiencing a revival in psychiatry.
Hundreds of protests at Tesla showrooms have also weighed on the company. Under the banner of a “Tesla Takedown,” opponents ...
Frontotemporal disorders (FTD) encompass a group of neurodegenerative conditions affecting the frontal and temporal lobes of the brain, leading to progressive cognitive and behavioral decline. As ...
GSK's Blenrep (belantamab mafodotin) has officially been approved by the UK's Medicines and Healthcare products Regulatory ...
According to DelveInsight's analysis, the market for GIST is anticipated to increase during the forecast period (2025–2034), owing to the launch of e ...
Growth Drivers include demand for protein-based drugs, rise in chronic disease prevalence, precision medicine expansion, biotech advancements, and AI-driven design tools.Dublin, April 14, 2025 (GLOBE ...
These followed two deals late last week – on Thursday GSK made an $85 million licensing agreement with Surface Oncology for an early-stage antibody asset, which adds a natural killer cell ...
GSK plc (LSE/NYSE: GSK) today announced the recipients of its COiMMUNITY Initiative grant program, awarding nearly $2 million to 15 regional, state and national non-profits and community-based groups ...
The year marked the third-largest contraction of the global art market in the past 15 years, the report found, eclipsed only by the years of the 2009 recession (-36%), and the 2020 Covid-19 ...
Chris Krebs defied Trump in 2020 by declaring the presidential election the most secure in U.S. history. Writing as "Anonymous," Miles Taylor authored an essay attacking chaos in Trump's first ...
Amid the current market turmoil, it is worth remembering that the pharmaceutical industry must continue its normal business of ensuring that it has products to sell in 10 years, with GSK (GSK) signing ...
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the ...